|
⚲
|
| Keyboard |
| Hudson Frederick M
✚
|
|
|---|---|
| CIK # | 0001438462 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001438462] | |
| 4 | [0001438462] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Hudson Frederick M | |
| Supernus Pharmaceuticals Inc | |
| scPharmaceuticals Inc | |
| Aradigm Corp |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Supernus Pharmaceuticals Inc SUPN
Common Stock
|
2026-03-12 | Sell | 5,369 | $50.61 | 271,725 |
|
Supernus Pharmaceuticals Inc SUPN
Common Stock
|
2026-02-24 | Grant | 4,475 | $0.00 | |
|
Supernus Pharmaceuticals Inc SUPN
Restricted Stock Unit · derivative
|
2026-02-24 | Disposed to issuer | 4,475 | $0.00 | |
|
Supernus Pharmaceuticals Inc SUPN
Director Stock Option (Right to Buy) · derivative
|
2026-02-18 | Grant | 4,977 | $0.00 | |
|
Supernus Pharmaceuticals Inc SUPN
Restricted Stock Unit · derivative
|
2026-02-18 | Grant | 2,989 | $0.00 | |
|
Supernus Pharmaceuticals Inc SUPN
Director Stock Option (Right to Buy) · derivative
|
2026-01-09 | Option exercise | 15,000 | $0.00 | |
|
Supernus Pharmaceuticals Inc SUPN
Common Stock
|
2026-01-09 | Option exercise | 15,000 | $12.98 | 194,700 |
|
scPharmaceuticals Inc SCPH
Stock Option (Right to Buy) · derivative
|
2025-10-07 | Disposed to issuer | 19,750 | $0.00 | |
|
scPharmaceuticals Inc SCPH
Stock Option (Right to Buy) · derivative
|
2025-10-07 | Disposed to issuer | 30,000 | $0.00 | |
|
scPharmaceuticals Inc SCPH
Stock Option (Right to Buy) · derivative
|
2025-10-07 | Disposed to issuer | 16,300 | $0.00 | |
|
scPharmaceuticals Inc SCPH
Stock Option (Right to Buy) · derivative
|
2025-10-07 | Disposed to issuer | 6,124 | $0.00 | |
|
Supernus Pharmaceuticals Inc SUPN
Common Stock
|
2025-08-14 | Sell | 7,457 | $42.26 | 315,133 |
|
scPharmaceuticals Inc SCPH
Stock Option (Right to Buy) · derivative
|
2025-06-03 | Grant | 30,000 | $0.00 | |
|
Supernus Pharmaceuticals Inc SUPN
Restricted Stock Units · derivative
|
2025-02-22 | Disposed to issuer | 5,369 | $0.00 | |
|
Supernus Pharmaceuticals Inc SUPN
Common Stock
|
2025-02-22 | Grant | 5,369 | $0.00 | |
|
Supernus Pharmaceuticals Inc SUPN
Director Stock Option (Right to Buy) · derivative
|
2025-02-19 | Grant | 7,296 | $0.00 | |
|
Supernus Pharmaceuticals Inc SUPN
Restricted Stock Unit · derivative
|
2025-02-19 | Grant | 4,475 | $0.00 | |
|
Supernus Pharmaceuticals Inc SUPN
Common Stock
|
2025-01-22 | Option exercise | 20,000 | $9.13 | 182,600 |
|
Supernus Pharmaceuticals Inc SUPN
Director Stock Option (Right to Buy) · derivative
|
2025-01-22 | Option exercise | 20,000 | $0.00 | |
|
Supernus Pharmaceuticals Inc SUPN
Common Stock
|
2024-11-08 | Sell | 8,722 | $36.28 | 316,434 |
| showing 20 of 67 most recent transactions | |||||